Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Low Frequencies of Autoimmunity-Associated PTPN22 Polymorphisms in MODY Patients, Including Those Transiently Expressing Islet Cell Autoantibodies

P. Heneberg, M. Malá, T. Yorifuji, G. Gat-Yablonski, Y. Lebenthal, T. Tajima, V. Nogaroto, B. Rypáčková, L. Kocková, J. Urbanová, M. Anděl,

. 2015 ; 166 (3) : 189-198. [pub] 20150418

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031378

Grantová podpora
NT13663 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 1998-01-01 do 2015-12-31
Medline Complete (EBSCOhost) od 1998-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1998-01-01 do 2015-12-31

BACKGROUND: The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes lymphoid tyrosine phosphatase (LYP), which is expressed primarily in lymphoid tissues. The functional but geographically highly variable PTPN22 single-nucleotide polymorphisms (SNPs), particularly c.1858C>T, contribute to the onset and progression of autoimmunity-associated diseases and facilitate the expression of disease-associated autoantibodies. In Central Europe, 17-25% of patients with monogenic diabetes (maturity-onset diabetes of the young, MODY) transiently express islet cell autoantibodies. METHODS: We addressed the links between the functional and geographically variable PTPN22 SNPs with MODY manifestation and the expression of islet cell autoantibodies in 276 MODY patients who originated from four regions (the Czech Republic, Israel, Japan and Brazil). RESULTS: The frequency of PTPN22 polymorphisms in the MODY patients was similar to those in geographically matched healthy populations, with the exception of c.788G>A, the minor allele frequency of which was significantly elevated in the Czech hepatocyte nuclear factor 1-α (HNF1A) MODY patients [odds ratio (OR) 4.8, 95% confidence interval (CI) 2.2-10.7] and the Brazilian MODY patients (OR 8.4, 95% CI 1.8-39.1). A barely significant increase in the c.788G>A minor allele was also detected in the islet cell autoantibody-positive Czech MODY patients. However, c.788A behaves as a loss-of-function mutant in T cells, and thus protects against autoimmunity. CONCLUSIONS: MODY patients (including islet cell autoantibody-positive cases) do not display any increase in autoimmunity-associated PTPN22 alleles. The absence of autoimmunity-associated PTPN22 alleles was also demonstrated in latent autoimmune diabetes in adults, which suggests that the slow kinetics of the onset of autoantibodies is subject to a regulation that is different from that experienced in type 1 diabetes and other autoimmune disorders.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031378
003      
CZ-PrNML
005      
20170524103310.0
007      
ta
008      
151005s2015 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000380853 $2 doi
035    __
$a (PubMed)25896041
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Heneberg, Petr, $u Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $d 1980- $7 mzk2007401181
245    10
$a Low Frequencies of Autoimmunity-Associated PTPN22 Polymorphisms in MODY Patients, Including Those Transiently Expressing Islet Cell Autoantibodies / $c P. Heneberg, M. Malá, T. Yorifuji, G. Gat-Yablonski, Y. Lebenthal, T. Tajima, V. Nogaroto, B. Rypáčková, L. Kocková, J. Urbanová, M. Anděl,
520    9_
$a BACKGROUND: The protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene encodes lymphoid tyrosine phosphatase (LYP), which is expressed primarily in lymphoid tissues. The functional but geographically highly variable PTPN22 single-nucleotide polymorphisms (SNPs), particularly c.1858C>T, contribute to the onset and progression of autoimmunity-associated diseases and facilitate the expression of disease-associated autoantibodies. In Central Europe, 17-25% of patients with monogenic diabetes (maturity-onset diabetes of the young, MODY) transiently express islet cell autoantibodies. METHODS: We addressed the links between the functional and geographically variable PTPN22 SNPs with MODY manifestation and the expression of islet cell autoantibodies in 276 MODY patients who originated from four regions (the Czech Republic, Israel, Japan and Brazil). RESULTS: The frequency of PTPN22 polymorphisms in the MODY patients was similar to those in geographically matched healthy populations, with the exception of c.788G>A, the minor allele frequency of which was significantly elevated in the Czech hepatocyte nuclear factor 1-α (HNF1A) MODY patients [odds ratio (OR) 4.8, 95% confidence interval (CI) 2.2-10.7] and the Brazilian MODY patients (OR 8.4, 95% CI 1.8-39.1). A barely significant increase in the c.788G>A minor allele was also detected in the islet cell autoantibody-positive Czech MODY patients. However, c.788A behaves as a loss-of-function mutant in T cells, and thus protects against autoimmunity. CONCLUSIONS: MODY patients (including islet cell autoantibody-positive cases) do not display any increase in autoimmunity-associated PTPN22 alleles. The absence of autoimmunity-associated PTPN22 alleles was also demonstrated in latent autoimmune diabetes in adults, which suggests that the slow kinetics of the onset of autoantibodies is subject to a regulation that is different from that experienced in type 1 diabetes and other autoimmune disorders.
650    _2
$a dospělí $7 D000328
650    _2
$a autoprotilátky $x krev $7 D001323
650    _2
$a autoimunitní nemoci $x genetika $x imunologie $7 D001327
650    _2
$a autoimunita $x genetika $x imunologie $7 D015551
650    _2
$a diabetes mellitus 2. typu $x genetika $x imunologie $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a Langerhansovy ostrůvky $x cytologie $x imunologie $7 D007515
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a tyrosinfosfatasa nereceptorového typu 22 $x genetika $7 D054596
650    _2
$a T-lymfocyty $x imunologie $7 D013601
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Brazílie $7 D001938
651    _2
$a Česká republika $7 D018153
651    _2
$a Izrael $7 D007557
651    _2
$a Japonsko $7 D007564
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Malá, Milena
700    1_
$a Yorifuji, Tohru
700    1_
$a Gat-Yablonski, Galia
700    1_
$a Lebenthal, Yael
700    1_
$a Tajima, Toshihiro
700    1_
$a Nogaroto, Viviane
700    1_
$a Rypáčková, Blanka $7 xx0171714
700    1_
$a Kocková, Lucie
700    1_
$a Urbanová, Jana
700    1_
$a Anděl, Michal, $d 1946- $7 jn19981228006
773    0_
$w MED00002269 $t International archives of allergy and immunology $x 1423-0097 $g Roč. 166, č. 3 (2015), s. 189-198
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25896041 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20170524103707 $b ABA008
999    __
$a ok $b bmc $g 1092254 $s 914504
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 166 $c 3 $d 189-198 $e 20150418 $i 1423-0097 $m International archives of allergy and immunology $n Int Arch Allergy Immunol $x MED00002269
GRA    __
$a NT13663 $p MZ0
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...